EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

C‐6‐Modified 2‐F‐Fucose Derivatives as Inhibitors of Fucosyltransferases

Yanyan Liu, Geert-Jan Boons iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202500624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Yanyan Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, Netherlands. Hauptthemen laut MEDLINE: Fucosyltransferases, Enzyme Inhibitors, Guanosine Diphosphate Fucose, Fucose. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Georgia, USA, Utrecht University, Chinese Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorinated analogs of guanosine‐diphosphate‐β‐L‐fucose (GDP‐Fuc) have received considerable attention for the development of inhibitors of fucosyltransferases (FUTs). These compounds can be recognized by FUTs but do not transfer or transfer slowly the fluorinated fucosyl residue because the electron‐withdrawing fluorine(s) destabilize the oxocarbenium‐like transition state. Fluorinated GDP‐Fuc analogs can also act as feedback inhibitor of the de novo biosynthetic pathway of GDP‐Fuc. To investigate the biological significance of distinct glycoconjugate classes, it is important to develop inhibitors that can selectively target specific FUT enzymes. The design, synthesis, and biological evaluation of a series of GDP‐2‐F‐Fuc analogs modified at C‐6 of Fuc by various amides and ethers are reported. Corresponding prodrugs are also prepared and examined as potential FUT inhibitors of cellular glycosylation. The findings reveal that two of the inhibitors potently inhibited FUT1, 3, 6, and 9, while displaying minimal activity against FUT8. However, the corresponding prodrugs do not inhibit cellular fucosylation, which is probably due to a lack of GDP‐fucose pyrophosphorylase activity. The results demonstrate that modifications at the C‐6 position of Fuc can confer selectivity, although further investigations of alternative functional groups are required to enhance cellular tolerance and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FucosyltransferasesEnzyme InhibitorsGuanosine Diphosphate FucoseFucoseHumansStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

fucosylationglycansinhibitorsprodrugsselectivitysynthesis

Substanzen

FucosyltransferasesEnzyme InhibitorsGuanosine Diphosphate FucoseFucose

Autor:innen und Institutionen

  • Division of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, Netherlands.
  • Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA.
  • Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, 3584 CH, Netherlands.
  • Chemistry Department, University of Georgia, Athens, GA, 30602, USA.

ORCID-Profile: Geert-Jan Boons

Förderung

  • University of Georgia, USA
  • Utrecht University
  • Chinese Scholarship Council

Zitieren

APA

Liu, Y., & Boons, G. J. (2025). C‐6‐Modified 2‐F‐Fucose Derivatives as Inhibitors of Fucosyltransferases. ChemBioChem. https://doi.org/10.1002/cbic.202500624

Vancouver

Liu Y, Boons GJ. C‐6‐Modified 2‐F‐Fucose Derivatives as Inhibitors of Fucosyltransferases. ChemBioChem. 2025. doi:10.1002/cbic.202500624

BibTeX
@article{Liu2025,
  author = {Liu, Yanyan and Boons, Geert-Jan},
  title = {C‐6‐Modified 2‐F‐Fucose Derivatives as Inhibitors of Fucosyltransferases},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202500624}
}
Kostenlos starten →